Physician profile
Russell C Feit
NPI 1942613989
$47,719.12
in general payments reported to CMS, 2019-2025
34 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,225 · 2020: $2,577 · 2021: $5,269 · 2022: $4,676 · 2023: $4,328 · 2024: $18K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $14K · Honoraria: $2,650 · Education: $17.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,018.75 |
| Food and Beverage | $14,284.70 |
| Honoraria | $2,650.00 |
| Education | $17.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elliquence, LLC | $13,500.00 | 2024-2025 | Disc-Fx System |
| Abbott Laboratories | $11,186.42 | 2019-2025 | Proclaim, Eterna, Octrode |
| Forte Bio-Pharma LLC | $4,169.43 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Spinal Simplicity, LLC | $3,379.70 | 2021-2025 | Ha Minuteman G3-R |
| Protega Pharmaceutials INC | $2,949.14 | 2024-2025 | Roxybond |
| Medtronic, INC. | $2,567.18 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Accurian |
| Biotronik Nro, INC. | $2,173.75 | 2023-2025 | Prospera, Biotronik |
| Boston Scientific Corporation | $1,750.21 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Vertos Medical, INC. | $1,553.09 | 2021-2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $942.64 | 2019-2025 | Xtampza, Belbuca |
| Nevro Corp. | $892.73 | 2019-2024 | Senza |
| Si-Bone, INC. | $693.88 | 2023-2025 | |
| Saluda Medical Americas, INC. | $388.15 | 2023-2024 | Evoke, Evoke Scs |
| Mml US, INC. | $376.04 | 2025 | Reactiv8 |
| Interventional Pain Technologies INC. | $206.37 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valinor Pharma, LLC | $184.12 | 2023-2025 | Movantik |
| Curonix LLC | $165.67 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Sentynl Therapeutics, INC. | $135.97 | 2019 | |
| Nalu Medical, INC. | $56.33 | 2023-2024 | Nalu Neurostimulation System |
| Scilex Pharmaceuticals INC. | $53.09 | 2021-2025 | |
| Averitas Pharma INC. | $43.38 | 2024-2025 | Qutenza |
| Virtus Pharmaceuticals LLC | $41.73 | 2021 | |
| Indivior INC. | $41.44 | 2025 | Sublocade |
| Biodelivery Sciences International, INC. | $41.37 | 2019-2021 | |
| Globus Medical, INC. | $40.03 | 2025 | Senza |
| Teva Pharmaceuticals USA, INC. | $28.71 | 2019 | |
| Alnylam Pharmaceuticals INC. | $28.03 | 2024 | Givlaari |
| Daiichi Sankyo INC. | $26.75 | 2019 | |
| Zyla Life Sciences, INC. | $26.31 | 2019 | |
| Redhill Biopharma INC. | $23.57 | 2022 | |
| Medtronic USA, INC. | $16.05 | 2020 | |
| Camber Spine Technologies LLC | $14.80 | 2023 | |
| Baudax Bio INC. | $11.77 | 2022 | |
| Horizon Therapeutics Plc | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Feit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.